LAMBERTVILLE, N.J., Oct. 26 /PRNewswire/ -- Addressing an increasingly complex payer dynamic in managed care, Health Strategies Group, a leading provider of market intelligence to pharmaceutical and biotechnology professionals, has launched a new service called Managed Care Complete that provides critical knowledge for optimizing physician and patient access to branded medications in 10 drug categories.
Managed Care Complete provides essential insights into the payer dynamic, identifies key influencers of brand access, and examines critical brand access decisions across major insurance plan types, including commercial, Medicare Part D, and Medicaid.
"For more than 15 years, we've conducted ongoing analysis of the payer landscape to determine brand access issues in more than 30 drug categories," said Susan Weber, director for brand access services at Health Strategies Group. "Our new Managed Care Complete service takes a deeper dive into the complexities of brand access and provides a complete picture of the managed care commercial environment as well as public payers in 10 specialized drug categories."
Those 10 categories are: anticoagulants/antiplatelets, antiretrovirals, autoimmune agents, asthma/COPD agents, breast cancer agents, hematologic cancer agents, hepatitis C agents, hypoglycemics, lung cancer agents, and multiple sclerosis agents.
Managed Care complete also provides access to Health Strategies Group brand access experts, who help clients apply the market intelligence to their specific business objectives.
For additional information on Managed Care Complete, contact Karen Vandeven, director of marketing communications, at (609) 397-5282 or firstname.lastname@example.org.
About Health Strategies Group
Health Strategies Group has been providing market intelligence to pharmaceutical and biotechnology professionals since 1992, transforming research findings into practical insights and strategic recommendations to help organizations make the best business decisions. The company has long-standing relationships with 90 percent of the nation's leading pharmaceutical and biotechnology companies.
Health Strategies Group services include syndicated research reports in different practice areas, proprietary intelligence projects on request, and direct, continuous access to a team of research directors and practice leaders who are experienced veterans of the pharmaceutical industry and active thought leaders in their areas of expertise. The company also creates a custom webpage for each client that provides ready access to all pertinent publications and research summaries.
Organizations use Health Strategies Group to assess marketplace trends and future scenarios, support business planning, formulate successful segmentation strategies, guide the design of training curricula, educate colleagues, benchmark staff performance, and develop more profitable contracting strategies.
Health Strategies Group is headquartered in Lambertville, N.J., with regional offices in Redwood City and Laguna Hills, Calif. Visit the company's Web site at www.HealthStrategies.com.
SOURCE Health Strategies Group